Skip to main content

Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink

Journal: Toxics
Lead Author: Geier, et al.
Original date of publication: 11/01/2018
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6316152/

Summary Context

This paper shows a dose-dependent increase in obesity and early puberty among children who received mercury-containing vaccines, mostly in the first two months of life.

Comments

This article is copyrighted by Health Freedom Defense Fund, Inc.
Visit our Re-post guidelines

This study shows a critical connection between mercury-containing vaccines and the very clear rise of premature puberty and obesity. This is particularly true for children injected in the first two months of life (odds ratio of 1.77 to 1) and first six months (odds ratio of 2.1 to 1)

Abstract or Results, Key Passages

“The results of this study show a dose-dependent association between increasing organic Hg exposure from Thimerosal-containing hepatitis B vaccines administered within the first six months of life and the long-term risk of the child being diagnosed with premature puberty.”


Keywords: adverse eventsEpidemiologyMercurymetabolismobesitypubertythimerosolvaccination
Full Author List: David A Geier, Janet K Kern, Mark R Geier